
Apollo Hospitals Q1 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- Healthcare Services revenue grew 15% YoY; expected continued double-digit volume growth driven by quality and insurance coverage expansion.
- Anticipated ARPOB growth improvement over next quarters due to better case mix and increased surgical volume.
- Hospitals to operationalize 4 new facilities (Gurgaon, Kolkata, Hyderabad, Pune) adding 1,500 beds over next 5 quarters, aiding volume growth.
- Pharmacy business expects 50% growth over last year, with recovery in Q2 and Q3 post-operating model changes.
- Apollo 24/7 platform GMV growing at 9%; growth expected to accelerate in next two quarters, targeting break-even in 6-7 quarters.
- Offline pharmacy store additions projected at 500–550 stores annually, boosting distribution revenue.
- Digital and corporate channels, insurance, and digital therapeutics seen as key drivers for future growth and margin expansion.
- Focus remains on volume-driven growth over ARPOB for sustainable profitability.
See what Apollo Hospitals management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what Apollo Hospitals management said on order book — free account, 30 seconds.
Capex plans
Yes- Apollo Hospitals plans to operationalize 4 new hospitals adding 1,500 beds in key markets: Gurgaon, Kolkata, Hyderabad, and Pune within the next 5 quarters.
- There is a brownfield expansion in Mysore with 140 beds.
- Investments are being made in expanding specialty manpower and diagnostic capacity.
- Apollo HealthCo is investing in omni-channel customer acquisition, digital therapeutics, insurance, and app monetization, aiming for breakeven in 6-7 quarters.
- The company is experimenting with faster medicine delivery models for acute/emergency customers.
- Cost optimization and calibrated growth investments are ongoing to support expansion while managing operational expenses.
Track Apollo Hospitals — get its next earnings analysis in your feed
How does Apollo Hospitals rank vs peers in Healthcare Services?
Pro featureHow does Apollo Hospitals rank in Healthcare Services?
Compare Apollo Hospitals against every Healthcare Services company (Q1 FY25) on revenue, margins and earnings-call signals.
Continue your research
What Apollo Hospitals's management said in earlier quarters
Others in Healthcare Services this season
- Chandan Healthca (Q2 FY27)
Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor
- Invicta Diagnostic (Q2 FY27)
Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2
- Unihealth Hosp (Q2 FY27)
1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r
- Sangani Hospital (Q2 FY27)
1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.